$AN2 Therapeutics (ANTX.US)$It will be risky if it cannot climb on $1.9~2.0 in the next week. But anyway, promising. Hopefully they really have some positive results.
$AN2 Therapeutics (ANTX.US)$Reuters· 1 min ago AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (Caused by Mycobacterium Tuberculosis) and Malaria
1
Report
Trytosaveabit
OP
:
Grant from the Bill & Melinda Gates Foundation
$AN2 Therapeutics (ANTX.US)$Plan to report Phase 2 topline results in August 2024 from ongoing Phase 2/3 trial (EBO-301) in treatment-refractory Mycobacterium avium Complex (TR-MAC) Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determined after review of unblinded Phase 2 data and discussions with the FDA
1
6
Report
NVDAvsTSLA
:
No one knows the results only the company themselves
Trytosaveabit
OP
NVDAvsTSLA
:
That’s why I said ( upcoming ) meaning later when they release the results/data! If it’s good it could be a catalyst. Hehehe
NVDAvsTSLA
:
Waiting for the 2/3 results. If they are good, the price goes up to 21, if fail, drop to 2. If succeed and be approved by FDA, they are going to the moon.
AN2 Therapeutics Stock Forum
I am in here for swing play. Chart looks good and insiders have been loading.
AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (Caused by Mycobacterium Tuberculosis) and Malaria
Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determined after review of unblinded Phase 2 data and discussions with the FDA
No comment yet